Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.79 USD | -4.28% | -10.50% | -84.68% |
May. 09 | EFFECTOR Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 04 | Health Care Down on Retreat From Risk -- Health Care Roundup | DJ |
Business Summary
Number of employees: 14
Managers
Managers | Title | Age | Since |
---|---|---|---|
Stephen Worland
CEO | Chief Executive Officer | 66 | 12-04-30 |
Michael Byrnes
DFI | Director of Finance/CFO | 47 | 20-11-30 |
Douglas Warner
CTO | Chief Tech/Sci/R&D Officer | 52 | 22-08-07 |
Mark Densel
PRN | Corporate Officer/Principal | - | 18-10-31 |
Mayank J. Gandhi
PRN | Corporate Officer/Principal | 47 | 22-09-25 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Worland
CEO | Chief Executive Officer | 66 | 12-04-30 |
Director/Board Member | 54 | 21-08-24 | |
Caroline Loewy
BRD | Director/Board Member | 58 | 23-09-10 |
Brian Gallagher
CHM | Chairman | 54 | 19-12-31 |
Barbara Klencke
BRD | Director/Board Member | 66 | 21-10-31 |
Elizabeth Bhatt
BRD | Director/Board Member | 56 | 21-08-24 |
Director/Board Member | 51 | 22-02-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,716,409 | 4,570,686 ( 96.91 %) | 12,000 ( 0.2544 %) | 96.91 % |
Company contact information
eFFECTOR Therapeutics, Inc.
142 North Cedros Avenue Suite B
92075, Solana Beach
+
http://www.effector.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-84.68% | 8.8M | |
+8.63% | 115B | |
+13.17% | 107B | |
-12.76% | 22.31B | |
-3.99% | 21.6B | |
-7.19% | 18.23B | |
-39.93% | 17.62B | |
+6.67% | 14.26B | |
+33.90% | 12.37B | |
-28.60% | 8.28B |
- Stock Market
- Equities
- EFTR Stock
- Company eFFECTOR Therapeutics, Inc.